logo
Dyess Airmen train for combat readiness at Peterson SFB

Dyess Airmen train for combat readiness at Peterson SFB

Yahoo2 days ago
PETERSON SPACE FORCE BASE, Colorado () – Aircrews and maintainers from the 28th Bomb Squadron recently completed a training exercise at Peterson Space Force Base, Colorado, as part of ongoing efforts to sustain readiness for Air Force Global Strike Command.
Flying out of Peterson SFB, the Dyess-based B-1B Lancers supported initial qualification, re-qualification, and instructor upgrade training, ensuring aircrews maintain combat capability across multiple skill levels.
'It's a mindset change': Retired major general outlines nuclear future for Dyess with arrival of B-21
The exercise was made possible with vital assistance from the 28th Bomber Generation Squadron, whose maintainers enabled the squadron to execute operations seamlessly from the off-station location.
Training in unfamiliar environments is essential to preparing aircrews for real-world missions. The exercise reinforces Air Force Global Strike Command's commitment to providing safe, secure, and effective strategic deterrence—anytime, anywhere.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

IMAX Format Will Make Galactus Feel Even More Terrifying in THE FANTASTIC FOUR
IMAX Format Will Make Galactus Feel Even More Terrifying in THE FANTASTIC FOUR

Geek Tyrant

time40 minutes ago

  • Geek Tyrant

IMAX Format Will Make Galactus Feel Even More Terrifying in THE FANTASTIC FOUR

When The Fantastic Four: First Steps lands in theaters on July 25, it won't just mark the debut of Marvel's First Family in the new MCU, it'll also deliver a cosmic heavyweight like never before, with Galactus. And if the villain's reputation as a planet-eating force of nature didn't already make him intimidating, director Matt Shakman is making sure the visuals will do the rest. In a new behind-the-scenes IMAX featurette, Shakman teased a unique visual treat: 'We designed the movie to be entirely in IMAX. You're going to space, but also you're in Manhattan, which is a vertical city, and we captured that scale. 'Then, you have the largest thing in the universe, and the world adjusts [makes hand gesture while video's aspect ratio changes]. This movie celebrates the IMAX format.' So yes, when Galactus arrives, you'll be able to experience the terrifying cosmic threat into an overwhelming presence that towers over everything else in the frame. Set in a 1960s-style retro-futuristic version of New York and beyond, the film stars Pedro Pascal as Reed Richards, Vanessa Kirby as Sue Storm, Joseph Quinn as Johnny Storm, and Ebon Moss-Bachrach as Ben Grimm. Julia Garner plays the Silver Surfer—though this time around, it's the Shalla-Bal version of the character—and Ralph Ineson brings his gravel-voiced gravitas to Galactus. The official synopsis reads: 'Set against the vibrant backdrop of a 1960s-inspired, retro-futuristic world, Marvel Studios' The Fantastic Four: First Steps introduces Marvel's First Family—Reed Richards/Mister Fantastic (Pedro Pascal), Sue Storm/Invisible Woman (Vanessa Kirby), Johnny Storm/Human Torch (Joseph Quinn) and Ben Grimm/The Thing (Ebon Moss-Bachrach) as they face their most daunting challenge yet. 'Forced to balance their roles as heroes with the strength of their family bond, they must defend Earth from a ravenous space god called Galactus (Ralph Ineson) and his enigmatic Herald, Silver Surfer (Julia Garner).' And if Galactus' plan to devour the entire planet and everyone on it weren't bad enough, it suddenly gets very personal. Also joining the ensemble are Paul Walter Hauser, Natasha Lyonne, and Sarah Niles each in still-undisclosed roles, which is just enough mystery to keep MCU fans speculating. The Fantastic Four: First Steps is aiming to be more than just an origin story, it's shaping up to be a full-on visual spectacle that takes the MCU cosmic in a whole new way. See it in IMAX on July 25 if you want to feel just how small we really are.

Star Trek: Strange New Worlds EPs Explain the Decision to End With Season 5 — How Close Will It Get to the Original Star Trek?
Star Trek: Strange New Worlds EPs Explain the Decision to End With Season 5 — How Close Will It Get to the Original Star Trek?

Yahoo

timean hour ago

  • Yahoo

Star Trek: Strange New Worlds EPs Explain the Decision to End With Season 5 — How Close Will It Get to the Original Star Trek?

Star Trek: Strange New Worlds already has a stardate in mind for its final voyage. Paramount+ announced in June that the Star Trek prequel will end with an upcoming fifth season of six episodes — which is still a long ways off, with Season 3 premiering this Thursday. So why did they decide Season 5 was the right time to put the Enterprise back in storage? More from TVLine Kamar de los Reyes, in His Final Role, Faces Off Against Tom Ellis in Washington Black - Watch (Exclusive) What to Watch This Week: 40+ Premieres, Finales and More Criminal Minds Boss Details Why Daniel Henney Won't Be Back After Wheel of Time Cancellation 'Well, Paramount+ felt that we had sort of exhausted the appetite for Strange New Worlds after [Season 4],' executive producer Akiva Goldsman tells TVLine, 'and we said, 'Well, remember, we made this promise to the fans that we get them right up to the edge of [the original Star Trek]'. And they were like, 'Oh yeah, we were part of that promise, too. What do you need to get there?' And we said, 'I think we can do it in six [episodes].' And they said, 'OK, do it in six.'' But with three more seasons still yet to air, Strange New Worlds isn't ready to say goodbye just yet. 'The audience has only seen 20 episodes' so far, EP Henry Alonso Myers reminds us. 'There's still 26 to go. More than you've seen already. So to talk about the end of the series now seems silly for us. It would be like if you'd seen Star Wars and then you went to see the trailer for The Empire Strikes Back, and you said, 'Well, and now it's over.' It is far from over.' Season 4 of Strange New Worlds is already filming, and 'we're building right now' the narrative structure of the fifth and final season, Goldsman teases. And with Strange New Worlds taking place right before the original Star Trek TV series, 'we'll try to get right up to Kirk's first day of command' of the Enterprise by the end of Season 5, he adds. That means we'll be seeing more of Paul Wesley as James T. Kirk in Strange New Worlds' final two seasons, Myers confirms: 'Yes, absolutely. No maybes about it.' What are you hoping to see as draws to a close? Beam down to the comments to share your thoughts. Best of TVLine Yellowjackets' Tawny Cypress Talks Episode 4's Tai/Van Reunion: 'We're All Worried About Taissa' Vampire Diaries Turns 10: How Real-Life Plot Twists Shaped Everything From the Love Triangle to the Final Death Vampire Diaries' Biggest Twists Revisited (and Explained)

Emerging Options in Second-Line Therapy for Metastatic NSCLC
Emerging Options in Second-Line Therapy for Metastatic NSCLC

Medscape

time2 hours ago

  • Medscape

Emerging Options in Second-Line Therapy for Metastatic NSCLC

Standard treatment of metastatic non-small cell lung cancer (NSCLC) is immunotherapy in the first line, followed by combination therapy with docetaxel and ramucirumab in the second line. But a new antibody-drug conjugate (ADC) and other drugs currently in development are broadening the options for these patients. Dr Tom Stinchcombe of Duke University in Durham, North Carolina, discusses ADCs, checkpoint inhibitors combined with tumor treating fields (TTF) therapy, and other targeted therapies being evaluated as second-ling therapies for metastatic NSCLC. Dr Stinchcombe first describes telisotuzumab vedotin, a c-Met-directed antibody and microtubule inhibitor conjugate indicated for metastatic NSCLC patients with high c-Met protein overexpression. The drug received FDA-accelerated approval on the basis of the LUMINOSITY trial, in which telisotuzumab vedotin monotherapy provided clinically meaningful response and progression-free survival in this population. He then describes TTF therapy, which delivers electrical impulses to the tumor site to disrupt processes critical for cancer cell division. The LUNAR trial showed the benefit of TTF plus checkpoint inhibition in second-line treatment of metastatic NSCLC, suggesting an additive benefit of this combination. Finally, he discussed two trials showing second-line therapies for patients with KRAS G12C mutations, in which sotorasib and adagrasib have shown potential benefit over docetaxel in this population.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store